XML 69 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interest
Beginning balance (deficit) at Dec. 31, 2009 $ 14,677 $ 15 $ 91,793 $ 313 $ (77,372) $ (72)
Beginning balance at Dec. 31, 2009   15,385,428        
Increase (Decrease) in Stockholders' Equity            
Net income 17,108       16,840 268
Foreign currency translation adjustments 169     169    
Cash flow hedge (379)     (379)    
Proceeds from exercise of stock options 1,773 1 1,772      
Proceeds from exercise of stock options (in shares)   385,027        
Issuance of stock grants 245   245      
Issuance of stock grants (in shares)   14,396        
Retirement of common stock (in shares)   (9,206)        
Non-cash stock-based compensation related to restricted stock units 2,065   2,065      
Tax benefit from exercise of stock options 1,416   1,416      
Distribution to noncontrolling interest (271)         (271)
Ending balance (deficit) at Dec. 31, 2010 36,803 16 97,291 103 (60,532) (75)
Ending balance at Dec. 31, 2010   15,775,645        
Increase (Decrease) in Stockholders' Equity            
Net income 18,278       17,900 378
Foreign currency translation adjustments (390)     (390)    
Cash flow hedge (31)     (31)    
Repurchase of common stock (7,544) (1) (7,543)      
Repurchase of common stock (in shares)   (461,512)        
Proceeds from exercise of stock options 217   217      
Proceeds from exercise of stock options (in shares)   68,322        
Issuance of stock grants 245   245      
Issuance of stock grants (in shares)   14,009        
Vested restricted stock units (in shares)   68,400        
Non-cash stock-based compensation related to restricted stock units 2,206   2,206      
Tax benefit from exercise of stock options 246   246      
Distribution to noncontrolling interest (388)         (388)
Ending balance (deficit) at Dec. 31, 2011 49,642 15 92,662 (318) (42,632) (85)
Ending balance at Dec. 31, 2011 15,464,864 15,464,864        
Increase (Decrease) in Stockholders' Equity            
Net income 4,154       3,120 1,034
Foreign currency translation adjustments 2     2    
Cash flow hedge (65)     (65)    
Shares issued-Central Merger 140,726 7 140,719      
Shares issued-Central Merger (in shares)   6,161,332        
Proceeds from exercise of stock options 526   526      
Proceeds from exercise of stock options (in shares)   81,023        
Issuance of stock grants 165   165      
Issuance of stock grants (in shares)   8,751        
Vested restricted stock units (in shares)   154,800        
Non-cash stock-based compensation related to restricted stock units 1,857   1,857      
Tax benefit from exercise of stock options 446   446      
Purchase of Central shares of noncontrolling interest 677         677
Distribution to noncontrolling interest (874)         (874)
Ending balance (deficit) at Dec. 31, 2012 $ 197,256 $ 22 $ 236,375 $ 571 $ (38,735) $ 752
Ending balance at Dec. 31, 2012 21,870,770 21,870,770